NATCO Pharma Limited (NSE:NATCOPHARM)
India
· Delayed Price · Currency is INR 1,042.95
+40.25 (4.01%)
Mar 10, 2026, 9:40 AM IST
NATCO Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Net Income | - | 18,854 | 13,883 | 7,153 | 1,700 | 4,409 | Upgrade
|
| Depreciation & Amortization | - | 1,812 | 1,822 | 1,592 | 1,394 | 1,145 | Upgrade
|
| Other Amortization | - | 40 | 46 | 46 | 32 | 24 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -901 | 17 | -178 | -427 | -320 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 530 | - | 23 | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -14 | 7 | 52 | -12 | - | Upgrade
|
| Stock-Based Compensation | - | - | - | - | 22 | 126 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -11 | 278 | -131 | 470 | 93 | Upgrade
|
| Other Operating Activities | - | -1,345 | -843 | -693 | -400 | -360 | Upgrade
|
| Change in Accounts Receivable | - | -593 | -3,413 | -2,223 | -2,389 | 1,306 | Upgrade
|
| Change in Inventory | - | -653 | 424 | 191 | 564 | -2,402 | Upgrade
|
| Change in Accounts Payable | - | 403 | -281 | 1,020 | 74 | -1,095 | Upgrade
|
| Change in Other Net Operating Assets | - | -1,154 | 176 | 1,639 | -563 | 62 | Upgrade
|
| Operating Cash Flow | - | 16,968 | 12,116 | 8,491 | 465 | 2,988 | Upgrade
|
| Operating Cash Flow Growth | - | 40.05% | 42.69% | 1726.02% | -84.44% | -28.40% | Upgrade
|
| Capital Expenditures | - | -4,011 | -3,394 | -1,463 | -2,328 | -2,546 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 950 | 20 | 305 | 538 | 451 | Upgrade
|
| Cash Acquisitions | - | - | - | - | -1,031 | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -904 | -193 | -593 | -99 | 23 | Upgrade
|
| Investment in Securities | - | -11,046 | -6,035 | -4,275 | 2,039 | -3,889 | Upgrade
|
| Other Investing Activities | - | 870 | -737 | 1,255 | 824 | 4,922 | Upgrade
|
| Investing Cash Flow | - | -14,145 | -10,327 | -4,771 | -53 | -1,033 | Upgrade
|
| Short-Term Debt Issued | - | - | 1,978 | - | 1,382 | - | Upgrade
|
| Total Debt Issued | - | - | 1,978 | - | 1,382 | - | Upgrade
|
| Short-Term Debt Repaid | - | -892 | - | -2,390 | - | -484 | Upgrade
|
| Long-Term Debt Repaid | - | -34 | -21 | -20 | -24 | -12 | Upgrade
|
| Total Debt Repaid | - | -926 | -21 | -2,410 | -24 | -496 | Upgrade
|
| Net Debt Issued (Repaid) | - | -926 | 1,957 | -2,410 | 1,358 | -496 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | - | 1 | Upgrade
|
| Repurchase of Common Stock | - | - | -2,537 | -74 | - | - | Upgrade
|
| Common Dividends Paid | - | -1,078 | -1,708 | -1,004 | -822 | -1,139 | Upgrade
|
| Other Financing Activities | - | -103 | -181 | -142 | -188 | -223 | Upgrade
|
| Financing Cash Flow | - | -2,107 | -2,469 | -3,630 | 348 | -1,857 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | -220 | 65 | 118 | 93 | -38 | Upgrade
|
| Net Cash Flow | - | 496 | -615 | 208 | 853 | 60 | Upgrade
|
| Free Cash Flow | - | 12,957 | 8,722 | 7,028 | -1,863 | 442 | Upgrade
|
| Free Cash Flow Growth | - | 48.55% | 24.10% | - | - | -28.25% | Upgrade
|
| Free Cash Flow Margin | - | 29.24% | 21.79% | 25.95% | -9.57% | 2.15% | Upgrade
|
| Free Cash Flow Per Share | - | 72.34 | 48.59 | 38.50 | -10.21 | 2.42 | Upgrade
|
| Cash Interest Paid | - | 176 | 181 | 142 | 170 | 128 | Upgrade
|
| Cash Income Tax Paid | - | 3,726 | 2,863 | 1,775 | 482 | 1,300 | Upgrade
|
| Levered Free Cash Flow | - | 8,409 | 4,610 | 1,964 | -1,849 | -385 | Upgrade
|
| Unlevered Free Cash Flow | - | 8,515 | 4,685 | 2,056 | -1,767 | -326.88 | Upgrade
|
| Change in Working Capital | - | -1,997 | -3,094 | 627 | -2,314 | -2,129 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.